These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Hyperthyroidism due to a thyroid-stimulating hormone (TSH)-secreting pituitary adenoma associated with functional hyperprolactinaemia. A case report. Savastano S; Lombardi G; Merola B; Miletto P; Di Prisco B; Manco A; Beck-Peccoz P; Faglia G Acta Endocrinol (Copenh); 1987 Dec; 116(4):452-8. PubMed ID: 3425160 [TBL] [Abstract][Full Text] [Related]
24. Human growth hormone-secreting pituitary adenoma cells in long-term culture: effects of dexamethasone and growth hormone releasing factor. Oosterom R; Verleun T; Lamberts SW J Endocrinol; 1984 Mar; 100(3):353-60. PubMed ID: 6421977 [TBL] [Abstract][Full Text] [Related]
25. [A case of pituitary adenoma with simultaneous secretion of TSH and GH detected by double immunostaining method]. Takechi A; Uozumi T; Mukada K; Kurisu K; Arita K; Yano T; Hirohata T; Ogasawara H; Ondo J; Hanaya R No To Shinkei; 1991 Aug; 43(8):775-9. PubMed ID: 1931260 [TBL] [Abstract][Full Text] [Related]
26. Evidence of a circulating growth hormone stimulating factor other than growth hormone releasing hormone in a patient with pituitary tumour and acromegaly. Hulting AL; Wersäll J; Werner S Acta Endocrinol (Copenh); 1985 Jul; 109(3):289-94. PubMed ID: 3927648 [TBL] [Abstract][Full Text] [Related]
27. Pathological study of thyrotropin-secreting pituitary adenoma: plurihormonality and medical treatment. Teramoto A; Sanno N; Tahara S; Osamura YR Acta Neuropathol; 2004 Aug; 108(2):147-53. PubMed ID: 15185102 [TBL] [Abstract][Full Text] [Related]
28. Hyperthyroidism and acromegaly due to a thyrotropin- and growth hormone-secreting pituitary tumor. Lack of hormonal response to bromocriptine. Carlson HE; Linfoot JA; Braunstein GD; Kovacs K; Young RT Am J Med; 1983 May; 74(5):915-23. PubMed ID: 6340497 [TBL] [Abstract][Full Text] [Related]
29. Identification of somatostatin receptors controlling growth hormone and thyrotropin secretion in the chicken using receptor subtype-specific agonists. Geris KL; de Groef B; Rohrer SP; Geelissen S; Kühn ER; Darras VM J Endocrinol; 2003 May; 177(2):279-86. PubMed ID: 12740016 [TBL] [Abstract][Full Text] [Related]
30. Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone. Joubert D; Benlot C; Lagoguey A; Garnier P; Brandi AM; Gautron JP; Legrand JC; Peillon F J Clin Endocrinol Metab; 1989 Mar; 68(3):572-7. PubMed ID: 2493037 [TBL] [Abstract][Full Text] [Related]
31. Serum alpha-subunit levels in patients with pituitary adenomas. Samejima N; Yamada S; Takada K; Sano T; Ozawa Y; Shimizu T; Usui M; Shishiba Y Clin Endocrinol (Oxf); 2001 Apr; 54(4):479-84. PubMed ID: 11318783 [TBL] [Abstract][Full Text] [Related]
32. Thyrotropin-releasing hormone stimulates growth hormone release from the anterior pituitary of hypothyroid rats in vitro. Szabo M; Stachura ME; Paleologos N; Bybee DE; Frohman LA Endocrinology; 1984 Apr; 114(4):1344-51. PubMed ID: 6423373 [TBL] [Abstract][Full Text] [Related]
33. Regulation of hormone release by cultured cells from a thyrotropin-growth hormone-secreting pituitary tumor. Direct inhibiting effects of 3,5,3'-triiodothyronine and dexamethasone on thyrotropin secretion. Lamberts SW; Oosterom R; Verleun T; Krenning EP; Assies H J Endocrinol Invest; 1984 Aug; 7(4):313-7. PubMed ID: 6438219 [TBL] [Abstract][Full Text] [Related]
34. Mammosomatotroph adenoma causing gigantism in an 8-year old boy: a possible pathogenetic mechanism. Dubuis JM; Deal CL; Drews RT; Goodyer CG; Lagacé G; Asa SL; Van Vliet G; Collu R Clin Endocrinol (Oxf); 1995 May; 42(5):539-49. PubMed ID: 7621575 [TBL] [Abstract][Full Text] [Related]
35. Pituitary adenomas with high and low basal inositol phospholipid turnover; the stimulatory effect of kinins and an association with interleukin-6 secretion. Jones TH; Kennedy RL; Justice SK; Price A Clin Endocrinol (Oxf); 1993 Oct; 39(4):433-9. PubMed ID: 8287569 [TBL] [Abstract][Full Text] [Related]
36. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture. Ishibashi M; Yamaji T J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273 [TBL] [Abstract][Full Text] [Related]
37. Heterogeneity of pituitary adenoma cell subpopulations from acromegalic patients obtained by Percoll density gradient centrifugation. Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW Acta Endocrinol (Copenh); 1989 Aug; 121(2):270-8. PubMed ID: 2549755 [TBL] [Abstract][Full Text] [Related]
38. A case of pituitary adenoma with possible simultaneous secretion of thyrotropin and follicle-stimulating hormone. Koide Y; Kugai N; Kimura S; Fujita T; Kameya T; Azukizawa M; Ogata E; Tomono Y; Yamashita K J Clin Endocrinol Metab; 1982 Feb; 54(2):397-403. PubMed ID: 6274903 [TBL] [Abstract][Full Text] [Related]
39. The growth hormone, prolactin and TSH response to TRH and L-dopa in patients with hyperprolactinaemia and a normal-sized sella turcica may denote a pituitary adenoma. Brismar K; Hulting AL; Werner S J Intern Med; 1990 Nov; 228(5):435-42. PubMed ID: 2123920 [TBL] [Abstract][Full Text] [Related]
40. The TSH secretion in the human pituitary adenomas. Trouillas J; Girod C; Loras B; Claustrat B; Sassolas G; Perrin G; Buonaguidi R Pathol Res Pract; 1988 Sep; 183(5):596-600. PubMed ID: 3237550 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]